LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Novel Strategies to Improve the Cardioprotective Effects of Cardioplegia.

    Osorio-Llanes, Estefanie / Castellar-López, Jairo / Rosales-Rada, Wendy / Montoya, Yulieth / Bustamante, John / Zalaquett, Ricardo / Bravo-Sagua, Roberto / Riquelme, Jaime A / Sánchez, Gina / Chiong, Mario / Lavandero, Sergio / Mendoza-Torres, Evelyn

    Current cardiology reviews

    2024  

    Abstract: The use of cardioprotective strategies as adjuvants of cardioplegic solutions has become an ideal alternative for the improvement of post-surgery heart recovery. The choice of the optimal cardioplegia, as well as its distribution mechanism, remains ... ...

    Abstract The use of cardioprotective strategies as adjuvants of cardioplegic solutions has become an ideal alternative for the improvement of post-surgery heart recovery. The choice of the optimal cardioplegia, as well as its distribution mechanism, remains controversial in the field of cardiovascular surgery. There is still a need to search for new and better cardioprotective methods during cardioplegic procedures. New techniques for the management of cardiovascular complications during cardioplegia have evolved with new alternatives and additives, and each new strategy provides a tool to neutralize the damage after ischemia/reperfusion events. Researchers and clinicians have committed themselves to studying the effect of new strategies and adjuvant components with the potential to improve the cardioprotective effect of cardioplegic solutions in preventing myocardial ischemia/reperfusion-induced injury during cardiac surgery. The aim of this review is to explore the different types of cardioplegia, their protection mechanisms, and which strategies have been proposed to enhance the function of these solutions in hearts exposed to cardiovascular pathologies that require surgical alternatives for their corrective progression.
    Language English
    Publishing date 2024-01-24
    Publishing country United Arab Emirates
    Document type Journal Article
    ISSN 1875-6557
    ISSN (online) 1875-6557
    DOI 10.2174/011573403X263956231129064455
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The Role of METTL3 in the Progression of Cardiac Fibrosis.

    Bolívar, Samir / Pérez-Cantillo, Marian / Monterroza-Torres, Jassiris / Vásquez-Trincado, César / Castellar-Lopez, Jairo / Mendoza-Torres, Evelyn

    Current topics in medicinal chemistry

    2023  Volume 23, Issue 26, Page(s) 2427–2435

    Abstract: Cardiac fibrosis is known as the expansion of the cardiac interstitium through excessive deposition of extracellular matrix proteins; this process is performed by a multifunctional cell known as the cardiac fibroblast. After the myocardial injury, these ... ...

    Abstract Cardiac fibrosis is known as the expansion of the cardiac interstitium through excessive deposition of extracellular matrix proteins; this process is performed by a multifunctional cell known as the cardiac fibroblast. After the myocardial injury, these cells are activated as a repair program, increase, and switch to a contractile phenotype, which is evidenced by an increase in alpha- smooth muscle actin. Likewise, there is an increase in type I and III collagen, which are considered profibrotic biomarkers. It is believed that one of the proteins involved in cardiac remodeling is METTL3, which is the enzyme responsible for N6-methyladenosine (m6A) methylation, the most common and abundant epigenetic modification of eukaryotic mRNA. This review focuses on recent studies in which the possible role of METTL3 in the progression of fibrosis has been demonstrated, mainly in cardiac fibrogenesis.
    MeSH term(s) Humans ; Methylation ; Fibrosis ; Epigenesis, Genetic ; Collagen/metabolism ; Fibroblasts ; Methyltransferases/metabolism
    Chemical Substances Collagen (9007-34-5) ; METTL3 protein, human (EC 2.1.1.62) ; Methyltransferases (EC 2.1.1.-)
    Language English
    Publishing date 2023-08-29
    Publishing country United Arab Emirates
    Document type Review ; Journal Article
    ZDB-ID 2064823-6
    ISSN 1873-4294 ; 1568-0266
    ISSN (online) 1873-4294
    ISSN 1568-0266
    DOI 10.2174/1568026623666230825144949
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Mechanisms of the Quorum Sensing Systems of Pseudomonas Aeruginosa: Host and Bacteria.

    Flores-Percino, Diana / Osorio-Llanes, Estefanie / Sepulveda, Yanireth / Castellar-López, Jairo / Belón Madera, Ricardo / Rosales, Wendy / Meléndez, Carlos Mario / Mendoza-Torres, Evelyn

    Current medicinal chemistry

    2023  

    Abstract: Quorum-sensing is a communication mechanism between bacteria with the ability to activate signaling pathways in the bacterium and in the host cells. Pseudomonas aeruginosa is a pathogen with high clinical relevance due to its vast virulence factors ... ...

    Abstract Quorum-sensing is a communication mechanism between bacteria with the ability to activate signaling pathways in the bacterium and in the host cells. Pseudomonas aeruginosa is a pathogen with high clinical relevance due to its vast virulence factors repertory and wide antibiotic resistance mechanisms. Due to this, it has become a pathogen of interest for developing new antimicrobial agents in recent years. P. aeruginosa has three major QS systems that regulate a wide gene range linked with virulence factors, metabolic regulation, and environment adaption. Consequently, inhibiting this communication mechanism would be a strategy to prevent the pathologic progression of the infections caused by this bacterium. In this review, we aim to overview the current studies about the signaling mechanisms of the QS system of P. aeruginosa and its effects on this bacterium and the host.
    Language English
    Publishing date 2023-08-21
    Publishing country United Arab Emirates
    Document type Journal Article
    ZDB-ID 1319315-6
    ISSN 1875-533X ; 0929-8673
    ISSN (online) 1875-533X
    ISSN 0929-8673
    DOI 10.2174/0929867331666230821110440
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Novel Insights into the Cardioprotective Effects of the Peptides of the Counter-Regulatory Renin-Angiotensin System.

    Gamiño-Gutiérrez, Janette Alejandra / Terán-Hernández, Ivana María / Castellar-Lopez, Jairo / Villamizar-Villamizar, Wendy / Osorio-Llanes, Estefanie / Palacios-Cruz, Mariali / Rosales, Wendy / Chang, Aileen Y / Díaz-Ariza, Luis Antonio / Ospino, María Clara / Mendoza-Torres, Evelyn

    Biomedicines

    2024  Volume 12, Issue 2

    Abstract: Currently, cardiovascular diseases are a major contributor to morbidity and mortality worldwide, having a significant negative impact on both the economy and public health. The renin-angiotensin system contributes to a high spectrum of cardiovascular ... ...

    Abstract Currently, cardiovascular diseases are a major contributor to morbidity and mortality worldwide, having a significant negative impact on both the economy and public health. The renin-angiotensin system contributes to a high spectrum of cardiovascular disorders and is essential for maintaining normal cardiovascular homeostasis. Overactivation of the classical renin-angiotensin system is one of the most important pathophysiological mechanisms in the progression of cardiovascular diseases. The counter-regulatory renin-angiotensin system is an alternate pathway which favors the synthesis of different peptides, including Angiotensin-(1-7), Angiotensin-(1-9), and Alamandine. These peptides, via the angiotensin type 2 receptor (AT2R), MasR, and MrgD, initiate multiple downstream signaling pathways that culminate in the activation of various cardioprotective mechanisms, such as decreased cardiac fibrosis, decreased myocardial hypertrophy, vasodilation, decreased blood pressure, natriuresis, and nitric oxide synthesis. These cardioprotective effects position them as therapeutic alternatives for reducing the progression of cardiovascular diseases. This review aims to show the latest findings on the cardioprotective effects of the main peptides of the counter-regulatory renin-angiotensin system.
    Language English
    Publishing date 2024-01-23
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines12020255
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms.

    Osorio-Llanes, Estefanie / Villamizar-Villamizar, Wendy / Ospino Guerra, María Clara / Díaz-Ariza, Luis Antonio / Castiblanco-Arroyave, Sara Camila / Medrano, Luz / Mengual, Daniela / Belón, Ricardo / Castellar-López, Jairo / Sepúlveda, Yanireth / Vásquez-Trincado, César / Chang, Aileen Y / Bolívar, Samir / Mendoza-Torres, Evelyn

    Pharmaceuticals (Basel, Switzerland)

    2023  Volume 16, Issue 8

    Abstract: The search for new drugs with the potential to ensure therapeutic success in the treatment of cardiovascular diseases has become an essential pathway to follow for health organizations and committees around the world. In June 2021, the World Health ... ...

    Abstract The search for new drugs with the potential to ensure therapeutic success in the treatment of cardiovascular diseases has become an essential pathway to follow for health organizations and committees around the world. In June 2021, the World Health Organization listed cardiovascular diseases as one of the main causes of death worldwide, representing 32% of them. The most common is coronary artery disease, which causes the death of cardiomyocytes, the cells responsible for cardiac contractility, through ischemia and subsequent reperfusion, which leads to heart failure in the medium and short term. Metformin is one of the most-used drugs for the control of diabetes, which has shown effects beyond the control of hyperglycemia. Some of these effects are mediated by the regulation of cellular energy metabolism, inhibiting apoptosis, reduction of cell death through regulation of autophagy and reduction of mitochondrial dysfunction with further reduction of oxidative stress. This suggests that metformin may attenuate left ventricular dysfunction induced by myocardial ischemia; preclinical and clinical trials have shown promising results, particularly in the setting of acute myocardial infarction. This is a review of the molecular and pharmacological mechanisms of the cardioprotective effects of metformin during myocardial ischemia-reperfusion injury.
    Language English
    Publishing date 2023-08-09
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2193542-7
    ISSN 1424-8247
    ISSN 1424-8247
    DOI 10.3390/ph16081121
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Potential of Angiotensin-(1-7) in COVID-19 Treatment.

    Luna, Patricia / Fernanda Pérez, María / Castellar-Lopez, Jairo / Chang, Aileen / Montoya, Yuliet / Bustamante, John / Rosales-Rada, Wendy / Mendoza-Torres, Evelyn

    Current protein & peptide science

    2022  Volume 24, Issue 1, Page(s) 89–97

    Abstract: The new coronavirus currently named SARS-CoV-2 was announced by the World Health Organization as the virus causing the COVID-19 pandemic. The pathogenesis of SARS-CoV-2 initiates upon contact of a structural spike protein with the angiotensin II- ... ...

    Abstract The new coronavirus currently named SARS-CoV-2 was announced by the World Health Organization as the virus causing the COVID-19 pandemic. The pathogenesis of SARS-CoV-2 initiates upon contact of a structural spike protein with the angiotensin II-converting enzyme receptor, leading to the induction of inflammatory mechanisms and progression to severe disease in some cases. Currently, studies have emerged linking COVID-19 with angiotensin-(1-7), demonstrating the potential of angiotensin-(1-7)/Mas Receptor axis induction to control disease severity due to its antiinflammatory, vasodilator, antioxidant, antiproliferative, anticoagulant, antiangiogenic and fibrosis inhibitory effects. The renin angiotensin-system peptide Angiotensin-(1-7) shows a high therapeutic potential for COVID-19 mainly because of its ability to counteract the adverse effects caused in various organs due to angiotensin II-converting enzyme blockade. In light of these factors, the use of convalescent plasma conjugated therapy and Ang (1-7) agonists for the treatment of COVID-19 patients could be recommended. The differential expression of ACE2 and the varied response to SARSCoV- 2 are thought to be connected. According to several investigations, ACE2 antibodies and pharmacological inhibitors might be used to prevent viral entry. Given its capacity to eliminate the virus while ensuring lung and cardiovascular protection by regulating the inflammatory response, angiotensin-( 1-7) is expected to be a safe choice. However, more clinical evidence is required to clarify the therapeutic usage of this peptide. The aim of this review article is to present an update of scientific data and clinical trials on the therapeutic potential of angiotensin-(1-7) in patients with COVID-19.
    MeSH term(s) Humans ; COVID-19 ; SARS-CoV-2/metabolism ; Angiotensin II/therapeutic use ; Angiotensin II/metabolism ; Angiotensin II/pharmacology ; Angiotensin-Converting Enzyme 2/metabolism ; Angiotensin-Converting Enzyme 2/pharmacology ; Pandemics ; COVID-19 Drug Treatment ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; COVID-19 Serotherapy ; Peptidyl-Dipeptidase A/metabolism ; Renin-Angiotensin System
    Chemical Substances angiotensin I (1-7) (IJ3FUK8MOF) ; Angiotensin II (11128-99-7) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) ; Angiotensin-Converting Enzyme Inhibitors ; Peptidyl-Dipeptidase A (EC 3.4.15.1)
    Language English
    Publishing date 2022-12-01
    Publishing country United Arab Emirates
    Document type Review ; Journal Article
    ZDB-ID 2045662-1
    ISSN 1875-5550 ; 1389-2037
    ISSN (online) 1875-5550
    ISSN 1389-2037
    DOI 10.2174/1389203724666221130140416
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Recent Insights into COVID-19 in Children and Clinical Recommendations.

    Castellar-López, Jairo / Villamizar-Villamizar, Wendy / Amaranto-Pallares, Aldo / Rosales-Rada, Wendy / De Los Angeles Vélez Verbel, Maria / Chang, Aileen / Jiménez, Franklin Torres / Mendoza-Torres, Evelyn

    Current pediatric reviews

    2021  Volume 18, Issue 2, Page(s) 121–137

    Abstract: Pediatric coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C) have been recognized in multiple countries globally. In this review, we provide recent insights into SARS-CoV-2 infection in children from ... ...

    Abstract Pediatric coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C) have been recognized in multiple countries globally. In this review, we provide recent insights into SARS-CoV-2 infection in children from epidemiological, clinical, and laboratory perspectives, including reports on the disease course and therapy. We highlight key features of SARS-CoV-2 infection in children, the relationship between MIS-C and Kawasaki disease, and summarize treatment guidelines for COVID-19 in children from institutional protocols from Colombia, case reports, recommendations based on expert consensus, and official statements from organizations such as the World Health Organization (WHO), United States Center for Disease Control (CDC), Colombian Association of Infectious Diseases, and the Colombian Society of Pediatrics. Finally, we discuss gaps in research with suggestions for future research on the pathogenesis underlying pediatric COVID-19.
    MeSH term(s) COVID-19/complications ; Child ; Humans ; Mucocutaneous Lymph Node Syndrome/diagnosis ; Mucocutaneous Lymph Node Syndrome/epidemiology ; Mucocutaneous Lymph Node Syndrome/therapy ; SARS-CoV-2 ; Systemic Inflammatory Response Syndrome/diagnosis ; Systemic Inflammatory Response Syndrome/therapy ; United States
    Language English
    Publishing date 2021-12-06
    Publishing country United Arab Emirates
    Document type Journal Article ; Review
    ISSN 1875-6336
    ISSN (online) 1875-6336
    DOI 10.2174/1573396317666211206124347
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Cytokine and T cell responses in post-chikungunya viral arthritis: A cross-sectional study.

    Chang, Aileen Y / Tritsch, Sarah R / Herrera Gomez, Carlos Andres / Encinales, Liliana / Cadena Bonfanti, Andres / Rosales, Wendy / Mendoza-Torres, Evelyn / Simmens, Samuel / Amdur, Richard L / Mores, Christopher N / Fierbaugh, Paige / Perez Hernandez, Carlos Alberto / Avendaño, Geraldine / Silvera, Paula Bruges / Crespo, Yerlenis Galvis / Jimenez, Alberto David Cabana / Martinez Zapata, Jennifer Carolina / Jimenez, Dennys / Osorio-Llanes, Estefanie /
    Castellar-Lopez, Jairo / Suchowiecki, Karol / Martins, Karen / Gregory, Melissa / Zuluaga, Ivan / Proctor, Abigale / Hernández, Alfonso Sucerquia / Sierra-Carrero, Leandro / Colpas, Maria Villanueva / Hernandez, Juan Carlos Perez / Quast, Andres Alberto Figueroa / De Barros, Joaquin Andres Calderon / Mejía, José Forero / Ruiz, Johan Penagos / Boyle, David / Firestein, Gary S / Simon, Gary L

    PloS one

    2024  Volume 19, Issue 3, Page(s) e0299521

    Abstract: Objective: To define the relationship between chronic chikungunya post-viral arthritis disease severity, cytokine response and T cell subsets in order to identify potential targets for therapy.: Methods: Participants with chikungunya arthritis were ... ...

    Abstract Objective: To define the relationship between chronic chikungunya post-viral arthritis disease severity, cytokine response and T cell subsets in order to identify potential targets for therapy.
    Methods: Participants with chikungunya arthritis were recruited from Colombia from 2019-2021. Arthritis disease severity was quantified using the Disease Activity Score-28 and an Arthritis-Flare Questionnaire adapted for chikungunya arthritis. Plasma cytokine concentrations (interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, interferon-γ and tumor necrosis factor (TNF)) were measured using a Meso Scale Diagnostics assay. Peripheral blood T cell subsets were measured using flow cytometry.
    Results: Among participants with chikungunya arthritis (N = 158), IL-2 levels and frequency of regulatory T cells (Tregs) were low. Increased arthritis disease activity was associated with higher levels of inflammatory cytokines (IL-6, TNF and CRP) and immunoregulatory cytokine IL-10 (p<0.05). Increased arthritis flare activity was associated with higher Treg frequencies (p<0.05) without affecting T effector (Teff) frequencies, Treg/Teff ratios and Treg subsets. Finally, elevated levels of IL-2 were correlated with increased Treg frequency, percent Tregs out of CD4+ T cells, and Treg subsets expressing immunosuppressive markers, while also correlating with an increased percent Teff out of live lymphocytes (p<0.05).
    Conclusion: Chikungunya arthritis is characterized by increased inflammatory cytokines and deficient IL-2 and Treg responses. Greater levels of IL-2 were associated with improved Treg numbers and immunosuppressive markers. Future research may consider targeting these pathways for therapy.
    MeSH term(s) Humans ; Cytokines/metabolism ; Interleukin-10/metabolism ; Cross-Sectional Studies ; Interleukin-2/metabolism ; Interleukin-6/metabolism ; Chikungunya Fever/complications ; T-Lymphocytes, Regulatory/metabolism ; CD4-Positive T-Lymphocytes/metabolism ; Tumor Necrosis Factor-alpha/metabolism ; Arthritis, Infectious ; Immunosuppressive Agents
    Chemical Substances Cytokines ; Interleukin-10 (130068-27-8) ; Interleukin-2 ; Interleukin-6 ; Tumor Necrosis Factor-alpha ; Immunosuppressive Agents
    Language English
    Publishing date 2024-03-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0299521
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top